EDGAR Filing Documents for 0001193125-12-139842

Form 8-K - Current report:

SEC Accession No. 0001193125-12-139842

Filing Date

2012-03-29

Accepted

2012-03-29 16:24:12

Documents

Period of Report

2012-03-28

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d324606d8k.htm	8-K	16931
2	LOAN AND SECURITY AGREEMENT	d324606dex101.htm	EX-10.1	224211
	Complete submission text file	0001193125-12-139842.txt		242500

Mailing Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807

Business Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807 (908) 704-1300

Aegerion Pharmaceuticals, Inc. (Filer) CIK: 0001338042 (see all company filings)